Mutations in FMS-like Tyrosine Kinase 3 (FLT3), such as internal tandem duplications (ITDs), are detected in up to 23% of acute myeloid leukemia (AML) patients and are frequently associated with poor prognosis [120]. The gene discussed is FLT3; the disease is acute myeloid leukemia.